Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Desert, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants, San Diego
mi
from
Poway, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants, San Diego
mi
from
Poway, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Riverside Medical Center
mi
from
Riverside, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Riverside Medical Center
mi
from
Riverside, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
UC Davis Medical Center, Department of Ophthalmology
mi
from
Sacramento, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
UC Davis Medical Center, Department of Ophthalmology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
West Coast Retina Medical Group
mi
from
San Francisco, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
West Coast Retina Medical Group
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Pacific Eye Associates
mi
from
San Francisco, CA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Pacific Eye Associates
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Macula Specialists of Miami
mi
from
Miami, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Macula Specialists of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
MedEye Associates
mi
from
Miami, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
MedEye Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Fort Lauderdale Eye Institute
mi
from
Plantation, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Fort Lauderdale Eye Institute
mi
from
Plantation, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Sarasota Retina Institute Research Foundation
mi
from
Sarasota, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Sarasota Retina Institute Research Foundation
mi
from
Sarasota, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
East Florida Eye Institute
mi
from
Stuart, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
East Florida Eye Institute
mi
from
Stuart, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associate of Florida, P.A.
mi
from
Tampa, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associate of Florida, P.A.
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Associates of Florida - Saint Petersburg
mi
from
Tampa, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Associates of Florida - Saint Petersburg
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Wheaton Eye Clinic, Clinical Research Center, LLC
mi
from
Wheaton, IL
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Wheaton Eye Clinic, Clinical Research Center, LLC
mi
from
Wheaton, IL
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Sabates Eye Centers
mi
from
Leawood, KA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Sabates Eye Centers
mi
from
Leawood, KA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
The Retina Care Center
mi
from
Baltimore, MD
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
The Retina Care Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Cumberland Valley Retina Consultants
mi
from
Hagerstown, MD
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Cumberland Valley Retina Consultants
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Vitreo-Retinal Associates, PC
mi
from
Worcester, MA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Vitreo-Retinal Associates, PC
mi
from
Worcester, MA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Center of New Jersey, LLC
mi
from
Bloomfield, NJ
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Center of New Jersey, LLC
mi
from
Bloomfield, NJ
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Delaware Valley Retina Associates
mi
from
Lawrenceville, NJ
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Delaware Valley Retina Associates
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Long Island Vitreoretinal Consultants
mi
from
Hauppauge, NY
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Long Island Vitreoretinal Consultants
mi
from
Hauppauge, NY
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Maculacare - New York
mi
from
New York, NY
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Maculacare - New York
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Surgeons
mi
from
Syracuse, NY
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Surgeons
mi
from
Syracuse, NY
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Western Carolina Retinal Associates
mi
from
Asheville, NC
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Western Carolina Retinal Associates
mi
from
Asheville, NC
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous Center of Southern Oregon, PC
mi
from
Ashland, OR
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous Center of Southern Oregon, PC
mi
from
Ashland, OR
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Retina Specialists, P.C.
mi
from
Camp Hill, PA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Retina Specialists, P.C.
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Black Hills Regional Eye Institute
mi
from
Rapid City, SD
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Black Hills Regional Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Austin Retina Associates
mi
from
Austin, TX
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Austin Retina Associates
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous of Texas
mi
from
Beaumont, TX
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous of Texas
mi
from
Beaumont, TX
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Premiere Retina Specialists
mi
from
Midland, TX
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Premiere Retina Specialists
mi
from
Midland, TX
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of South Texas
mi
from
San Antonio, TX
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Strategic Clinical Research Group, LLC
mi
from
Willow Park, TX
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Strategic Clinical Research Group, LLC
mi
from
Willow Park, TX
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Wagner Macula and Retina Center
mi
from
Virginia Beach, VA
Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Wagner Macula and Retina Center
mi
from
Virginia Beach, VA
Click here to add this to my saved trials